New psoriasis treatment goes Head-to-Head with established drug
NCT ID NCT06630559
Summary
This study aims to see if a new psoriasis medication called CT-P55 works as well and is as safe as an already approved drug called Cosentyx. It involves 153 adults with moderate to severe plaque psoriasis. Participants are randomly assigned to receive either the new treatment or the existing one, and neither they nor their doctors know which one they are getting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rheumatology Clinic NZOZ Lecznica MAK-MED s.c.
Nadarzyn, Poland
Conditions
Explore the condition pages connected to this study.